25 XP   0   0   10

Alvotech
Buy, Hold or Sell?

Let's analyse Alvotech together

PenkeI guess you are interested in Alvotech. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Alvotech. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Alvotech

I send you an email if I find something interesting about Alvotech.

Quick analysis of Alvotech (30 sec.)










What can you expect buying and holding a share of Alvotech? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr-3.34
Expected worth in 1 year
kr-6.67
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
kr-3.34
Return On Investment
-0.2%

For what price can you sell your share?

Current Price per Share
kr1,920.00
Expected price per share
kr1,510 - kr2,150
How sure are you?
50%

1. Valuation of Alvotech (5 min.)




Live pricePrice per Share (EOD)

kr1,920.00

2. Growth of Alvotech (5 min.)




Is Alvotech growing?

Current yearPrevious yearGrowGrow %
How rich?-$6.6m???

How much money is Alvotech making?

Current yearPrevious yearGrowGrow %
Making money-$137.9m???
Net Profit Margin248.5%?--

How much money comes from the company's main activities?

3. Financial Health of Alvotech (5 min.)




What can you expect buying and holding a share of Alvotech? (5 min.)

Welcome investor! Alvotech's management wants to use your money to grow the business. In return you get a share of Alvotech.

What can you expect buying and holding a share of Alvotech?

First you should know what it really means to hold a share of Alvotech. And how you can make/lose money.

Speculation

The Price per Share of Alvotech is kr1,920. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alvotech.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alvotech, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr-3.34. Based on the TTM, the Book Value Change Per Share is kr-0.83 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alvotech.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.99-0.1%-0.490.0%-0.490.0%-0.490.0%
Usd Book Value Change Per Share-0.010.0%-0.010.0%-0.010.0%-0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.010.0%-0.010.0%-0.010.0%-0.010.0%
Usd Price Per Share11.32-10.33-10.33-10.33-
Price to Earnings Ratio-2.86--1.65--1.65--1.65-
Price-to-Total Gains Ratio-1,631.25--652.56--652.56--652.56-
Price to Book Ratio-475.19--609.39--609.39--609.39-
Price-to-Total Gains Ratio-1,631.25--652.56--652.56--652.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.716245177883
Number of shares72
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.01
Usd Total Gains Per Share-0.01-0.01
Gains per Quarter (72 shares)-0.43-0.43
Gains per Year (72 shares)-1.72-1.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2-120-2-12
20-3-140-3-14
30-5-160-5-16
40-7-180-7-18
50-9-200-9-20
60-10-220-10-22
70-12-240-12-24
80-14-260-14-26
90-15-280-15-28
100-17-300-17-30

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%
Book Value Change Per Share1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%
Dividend per Share0.00.04.00.0%0.00.04.00.0%0.00.04.00.0%0.00.04.00.0%0.00.04.00.0%
Total Gains per Share1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%

Fundamentals of Alvotech

About Alvotech

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as age-related macular degeneration, macular edema, and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia, which is in the pre-clinical phase to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria, which is in early phase development to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product; AVT23, a biosimilar to Xolair, which is in late-stage development to treat nasal polyps; and AVT33, a biosimilar to an Keytruda product. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.

Fundamental data was last updated by Penke on 2024-04-19 20:57:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Alvotech.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Alvotech earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -518.0% means that kr-5.18 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alvotech:

  • The MRQ is -518.0%. The company is making a huge loss. -2
  • The TTM is 248.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-518.0%TTM248.5%-766.5%
TTM248.5%5Y248.5%0.0%
5Y248.5%10Y248.5%0.0%
1.1.2. Return on Assets

Shows how efficient Alvotech is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • -4,074.6% Return on Assets means that Alvotech generated kr-40.75 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alvotech:

  • The MRQ is -4,074.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2,057.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4,074.6%TTM-2,057.8%-2,016.9%
TTM-2,057.8%5Y-2,057.8%0.0%
5Y-2,057.8%10Y-2,057.8%0.0%
1.1.3. Return on Equity

Shows how efficient Alvotech is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Alvotech generated kr0.00 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alvotech:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%

1.2. Operating Efficiency of Alvotech.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Alvotech is operating .

  • Measures how much profit Alvotech makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alvotech:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Alvotech is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 3.50 means that the operating costs are kr3.50 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Alvotech:

  • The MRQ is 3.502. The company is inefficient in keeping operating costs low. -1
  • The TTM is 12.443. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.502TTM12.443-8.941
TTM12.4435Y12.4430.000
5Y12.44310Y12.4430.000

1.3. Liquidity of Alvotech.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Alvotech is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.75 means the company has kr0.75 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Alvotech:

  • The MRQ is 0.747. The company is unable to pay all its short-term debts. -2
  • The TTM is 1.151. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.747TTM1.151-0.404
TTM1.1515Y1.1510.000
5Y1.15110Y1.1510.000
1.3.2. Quick Ratio

Measures if Alvotech is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.16 means the company can pay off kr0.16 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alvotech:

  • The MRQ is 0.158. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.134. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.158TTM0.134+0.024
TTM0.1345Y0.1340.000
5Y0.13410Y0.1340.000

1.4. Solvency of Alvotech.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Alvotech assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alvotech to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.98 means that Alvotech assets are financed with 198.1% credit (debt) and the remaining percentage (100% - 198.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alvotech:

  • The MRQ is 1.981. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.732. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.981TTM1.732+0.249
TTM1.7325Y1.7320.000
5Y1.73210Y1.7320.000
1.4.2. Debt to Equity Ratio

Measures if Alvotech is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has kr0.00 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alvotech:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-5Y-0.000
5Y-10Y-0.000

2. Market Valuation of Alvotech

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Alvotech generates.

  • Above 15 is considered overpriced but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -2.86 means the investor is paying kr-2.86 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alvotech:

  • The EOD is -3.466. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.862. Based on the earnings, the company is expensive. -2
  • The TTM is -1.646. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.466MRQ-2.862-0.605
MRQ-2.862TTM-1.646-1.216
TTM-1.6465Y-1.6460.000
5Y-1.64610Y-1.6460.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alvotech:

  • The EOD is -12.350. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.195. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.660. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.350MRQ-10.195-2.155
MRQ-10.195TTM-8.660-1.535
TTM-8.6605Y-8.6600.000
5Y-8.66010Y-8.6600.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Alvotech is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -475.19 means the investor is paying kr-475.19 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Alvotech:

  • The EOD is -575.628. Based on the equity, the company is expensive. -2
  • The MRQ is -475.193. Based on the equity, the company is expensive. -2
  • The TTM is -609.392. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-575.628MRQ-475.193-100.435
MRQ-475.193TTM-609.392+134.200
TTM-609.3925Y-609.3920.000
5Y-609.39210Y-609.3920.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Alvotech compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.972-0.834-14%---0.834-14%-0.834-14%
Book Value Per Share---3.335-2.439-27%---2.439-27%-2.439-27%
Current Ratio--0.7471.151-35%--1.151-35%1.151-35%
Debt To Asset Ratio--1.9811.732+14%--1.732+14%1.732+14%
Debt To Equity Ratio----0%---0%-0%
Dividend Per Share----0%---0%-0%
Eps---138.473-69.063-50%---69.063-50%-69.063-50%
Free Cash Flow Per Share---38.867-44.895+16%---44.895+16%-44.895+16%
Free Cash Flow To Equity Per Share---28.522-7.177-75%---7.177-75%-7.177-75%
Gross Profit Margin--1.0001.0000%--1.0000%1.0000%
Market Cap536768655360.000+17%443113707680.000404323785320.000+10%--404323785320.000+10%404323785320.000+10%
Net Profit Margin---5.1802.485-308%--2.485-308%2.485-308%
Operating Margin----0%---0%-0%
Operating Ratio--3.50212.443-72%--12.443-72%12.443-72%
Pb Ratio-575.628-21%-475.193-609.392+28%---609.392+28%-609.392+28%
Pe Ratio-3.466-21%-2.862-1.646-42%---1.646-42%-1.646-42%
Price Per Share1920.000+17%1585.0001446.250+10%--1446.250+10%1446.250+10%
Price To Free Cash Flow Ratio-12.350-21%-10.195-8.660-15%---8.660-15%-8.660-15%
Price To Total Gains Ratio-1976.022-21%-1631.248-652.564-60%---652.564-60%-652.564-60%
Quick Ratio--0.1580.134+18%--0.134+18%0.134+18%
Return On Assets---40.746-20.578-49%---20.578-49%-20.578-49%
Return On Equity----0%---0%-0%
Total Gains Per Share---0.972-0.834-14%---0.834-14%-0.834-14%
Usd Book Value---6661615.945-4871503.072-27%---4871503.072-27%-4871503.072-27%
Usd Book Value Change Per Share---0.007-0.006-14%---0.006-14%-0.006-14%
Usd Book Value Per Share---0.024-0.017-27%---0.017-27%-0.017-27%
Usd Dividend Per Share----0%---0%-0%
Usd Eps---0.989-0.493-50%---0.493-50%-0.493-50%
Usd Free Cash Flow---77625000.000-89664500.000+16%---89664500.000+16%-89664500.000+16%
Usd Free Cash Flow Per Share---0.278-0.321+16%---0.321+16%-0.321+16%
Usd Free Cash Flow To Equity Per Share---0.204-0.051-75%---0.051-75%-0.051-75%
Usd Market Cap3834609625.375+17%3165550133.4482888439672.239+10%--2888439672.239+10%2888439672.239+10%
Usd Price Per Share13.716+17%11.32310.332+10%--10.332+10%10.332+10%
Usd Profit---276557000.000-137932750.000-50%---137932750.000-50%-137932750.000-50%
Usd Revenue--53390000.00022858500.000+134%--22858500.000+134%22858500.000+134%
Usd Total Gains Per Share---0.007-0.006-14%---0.006-14%-0.006-14%
 EOD+6 -2MRQTTM+11 -19YOY+0 -05Y+11 -1910Y+11 -19

3.2. Fundamental Score

Let's check the fundamental score of Alvotech based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.466
Price to Book Ratio (EOD)Between0-1-575.628
Net Profit Margin (MRQ)Greater than0-5.180
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.158
Current Ratio (MRQ)Greater than10.747
Debt to Asset Ratio (MRQ)Less than11.981
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-40.746
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Alvotech based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.151
Ma 20Greater thanMa 501,755.750
Ma 50Greater thanMa 1002,007.700
Ma 100Greater thanMa 2001,853.375
OpenGreater thanClose1,905.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in ISK. All numbers in thousands.

Summary
Total Assets950,090
Total Liabilities1,882,583
Total Stockholder Equity-932,493
 As reported
Total Liabilities 1,882,583
Total Stockholder Equity+ -932,493
Total Assets = 950,090

Assets

Total Assets950,090
Total Current Assets194,842
Long-term Assets755,248
Total Current Assets
Cash And Cash Equivalents 11,157
Net Receivables 41,292
Inventory 74,433
Total Current Assets  (as reported)194,842
Total Current Assets  (calculated)126,882
+/- 67,960
Long-term Assets
Property Plant Equipment 356,581
Goodwill 12,058
Long Term Investments 18,494
Intangible Assets 19,076
Long-term Assets Other 28,376
Long-term Assets  (as reported)755,248
Long-term Assets  (calculated)434,585
+/- 320,663

Liabilities & Shareholders' Equity

Total Current Liabilities260,950
Long-term Liabilities1,621,633
Total Stockholder Equity-932,493
Total Current Liabilities
Short Long Term Debt 38,025
Accounts payable 80,563
Total Current Liabilities  (as reported)260,950
Total Current Liabilities  (calculated)118,588
+/- 142,362
Long-term Liabilities
Long term Debt 922,134
Capital Lease Obligations Min Short Term Debt115,315
Long-term Liabilities  (as reported)1,621,633
Long-term Liabilities  (calculated)1,037,449
+/- 584,184
Total Stockholder Equity
Total Stockholder Equity (as reported)-932,493
Total Stockholder Equity (calculated)0
+/- 932,493
Other
Capital Stock2,279
Common Stock Shares Outstanding 266,822
Net Debt 949,002
Net Invested Capital 27,666
Net Working Capital -66,108
Property Plant and Equipment Gross 424,710



Balance Sheet

Currency in ISK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-31
> Total Assets 
895,465
910,662
958,819
950,090
950,090958,819910,662895,465
   > Total Current Assets 
269,141
211,912
228,391
194,842
194,842228,391211,912269,141
       Cash And Cash Equivalents 
115,844
60,466
68,315
11,157
11,15768,31560,466115,844
       Net Receivables 
30,020
16,307
21,945
41,292
41,29221,94516,30730,020
       Inventory 
75,236
79,366
81,995
74,433
74,43381,99579,36675,236
       Other Current Assets 
31,799
0
36,031
0
036,031031,799
   > Long-term Assets 
626,324
698,750
730,428
755,248
755,248730,428698,750626,324
       Property Plant Equipment 
272,321
333,391
343,462
356,581
356,581343,462333,391272,321
       Goodwill 
11,911
11,886
11,555
12,058
12,05811,55511,88611,911
       Long Term Investments 
47,586
43,613
42,035
18,494
18,49442,03543,61347,586
       Intangible Assets 
14,527
14,007
20,283
19,076
19,07620,28314,00714,527
       Long-term Assets Other 
27,199
27,240
27,144
28,376
28,37627,14427,24027,199
> Total Liabilities 
1,551,232
1,389,202
1,619,671
1,882,583
1,882,5831,619,6711,389,2021,551,232
   > Total Current Liabilities 
160,334
221,693
186,754
260,950
260,950186,754221,693160,334
       Short Long Term Debt 
23,048
22,463
13,594
38,025
38,02513,59422,46323,048
       Accounts payable 
29,766
43,931
52,662
80,563
80,56352,66243,93129,766
       Other Current Liabilities 
75,100
0
55,590
0
055,590075,100
   > Long-term Liabilities 
1,390,898
1,167,509
1,432,917
1,621,633
1,621,6331,432,9171,167,5091,390,898
       Long term Debt 
770,656
786,175
898,483
922,134
922,134898,483786,175770,656
       Capital Lease Obligations Min Short Term Debt
42,087
95,399
102,954
115,315
115,315102,95495,39942,087
> Total Stockholder Equity
-655,767
-478,540
-660,852
-932,493
-932,493-660,852-478,540-655,767
   Common Stock0000
   Retained Earnings Total Equity0000
   Accumulated Other Comprehensive Income 0000
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 0000



Balance Sheet

Currency in ISK. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue91,434
Cost of Revenue-160,856
Gross Profit-69,422-69,422
 
Operating Income (+$)
Gross Profit-69,422
Operating Expense-446,294
Operating Income-354,860-515,716
 
Operating Expense (+$)
Research Development210,827
Selling General Administrative76,559
Selling And Marketing Expenses-
Operating Expense446,294287,386
 
Net Interest Income (+$)
Interest Income4,823
Interest Expense-133,167
Other Finance Cost-1,657
Net Interest Income-130,001
 
Pretax Income (+$)
Operating Income-354,860
Net Interest Income-130,001
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-651,049-188,672
EBIT - interestExpense = -133,167
-551,731
-418,564
Interest Expense133,167
Earnings Before Interest and Taxes (EBIT)--517,882
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-651,049
Tax Provision--99,318
Net Income From Continuing Ops-551,731-551,731
Net Income-551,731
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-166,188130,001
 

Technical Analysis of Alvotech
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alvotech. The general trend of Alvotech is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alvotech's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alvotech.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2,100 < 2,120 < 2,150.

The bearish price targets are: 1,655 > 1,560 > 1,510.

Tweet this
Alvotech Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alvotech. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alvotech Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alvotech. The current macd is -27.1928724.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Alvotech price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Alvotech. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Alvotech price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Alvotech Daily Moving Average Convergence/Divergence (MACD) ChartAlvotech Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alvotech. The current adx is 27.19.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Alvotech shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Alvotech Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alvotech. The current sar is 1,707.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Alvotech Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alvotech. The current rsi is 56.15. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Alvotech Daily Relative Strength Index (RSI) ChartAlvotech Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alvotech. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Alvotech price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Alvotech Daily Stochastic Oscillator ChartAlvotech Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alvotech. The current cci is 126.61.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Alvotech Daily Commodity Channel Index (CCI) ChartAlvotech Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alvotech. The current cmo is 29.79.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Alvotech Daily Chande Momentum Oscillator (CMO) ChartAlvotech Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alvotech. The current willr is -5.35714286.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Alvotech Daily Williams %R ChartAlvotech Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alvotech.

Alvotech Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alvotech. The current atr is 61.54.

Alvotech Daily Average True Range (ATR) ChartAlvotech Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alvotech. The current obv is 23,217,949.

Alvotech Daily On-Balance Volume (OBV) ChartAlvotech Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alvotech. The current mfi is 82.59.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Alvotech Daily Money Flow Index (MFI) ChartAlvotech Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alvotech.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Alvotech Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alvotech based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.151
Ma 20Greater thanMa 501,755.750
Ma 50Greater thanMa 1002,007.700
Ma 100Greater thanMa 2001,853.375
OpenGreater thanClose1,905.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Alvotech with someone you think should read this too:
  • Are you bullish or bearish on Alvotech? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alvotech? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alvotech

I send you an email if I find something interesting about Alvotech.


Comments

How you think about this?

Leave a comment

Stay informed about Alvotech.

Receive notifications about Alvotech in your mailbox!